Morgan Stanley Capital Partners, a division of Morgan Stanley, announced that it has completed the sale of Clarity Software Solutions to mPulse. The transaction was supported by PSG, mPulse’s current majority investor, along with investments from other existing mPulse shareholders.
Clarity Software Solutions provides technology-driven healthcare engagement through multimodal communications. Each year, Clarity produces and delivers more than 150 million member communications for more than 100 health plans nationwide.
mPulse, a leader in conversational AI solutions for the healthcare industry, improves health outcomes and business efficiencies by engaging individuals. mPulse combines behavioral science, analytics and industry expertise that helps healthcare organizations activate their consumers to adopt healthy behaviors. PSG became the company’s majority shareholder in December 2021.
Steve Mongelli, CEO of Clarity, will continue in the role of President at mPulse and lead a broad set of functions that help drive leadership and innovation in the market and continuity across business processes. Financial terms of the deal were not disclosed.
William Blair served as lead financial advisor to Clarity, with Lincoln International acting as financial advisor. Dechert was retained as legal counsel and Alvarez & Marsal for financial diligence.
According to data in the LevinPro HC database, this transaction marks the 210th eHealth acquisition of 2025, and the 34th in the patient engagement specialty. There were 33 patient engagement acquisitions announced in 2024, and 17 announced in 2023.
